Orexo has recently invested in the interactive document and quality management system Advantum, tailored for the Life Science industry - Advantum Life Sciences Suite.
Orexo is a specialist pharmaceutical company with commercial operations in the USA and R&D in Sweden that develops improved medicines based on its own drug delivery technology. Orexo has expertise in the field of reformulation and above all in sublingual formulations. The company has a portfolio of revenue-generating products approved in the US and the EU, which are marketed through licensing agreements, as well as a pipeline consisting of several reformulations of approved substances in areas of medical need. Orexo also has collaborative projects with several international pharmaceutical companies
Advantum Life Sciences Suite offers an affordable solution specifically designed to help businesses in the Life Science industry implement a best practice system. Advantum is especially characterized by its safe handling of critical information as well as the unique flexibility that comes with a 100% configurable system. Advantum Life Sciences Suite is a pre-configured quality management solution in accordance with industry requirements from, for example, the EU and the FDA.
Learn more about Orexo here www.orexo.com
